In a recent conversation celebrating the 30th anniversary of the UK cancer charity Maggie’s, Queen Camilla spoke about the challenges of keeping King Charles III’s cancer diagnosis private during the initial stages of his treatment. The King was diagnosed with cancer in early 2024, with Buckingham Palace announcing the news in February.
:max_bytes(150000):strip_icc():format(jpeg)/Charles-Camilla-split-2-081926-1bd1e5d551bf4033b520e91610df3708.jpg)
Camilla, 79, revealed the emotional burden she faced while maintaining confidentiality regarding the King’s health. This revelation comes after Buckingham Palace disclosed that Charles, 77, had been diagnosed with a form of cancer following a procedure to treat an enlarged prostate. Since then, the King has been undergoing ongoing treatment for this unspecified illness.
Reflecting on her experience, the Queen expressed to Dame Laura Lee, the chief executive of Maggie’s, how difficult it was to remain silent. “Nobody could say anything at the time, that was quite difficult,” Camilla shared. According to the monarch, she felt the urge to disclose the information but ultimately decided it was not the right moment.
In January 2024, before the public announcement of Charles’ condition, Camilla had visited the newly inaugurated Maggie’s Royal Free centre at the Royal Free Hospital in London. During this visit, when asked about the King’s health, she commented that he was “doing his best,” hinting at the challenges they were facing without revealing full details.
During the discussion with Lee, Camilla acknowledged that visiting the Maggie’s centre just prior to the public announcement of her husband’s diagnosis required considerable courage. She emphasised how the experience deepened her understanding of the importance of cancer support facilities, saying, “It made me realise even more how important these places were.”
As the Queen continued, she divulged her evolving relationship with the patients and families at Maggie’s, admitting that she had been grappling with her husband’s diagnosis. “I was almost questioning them. I didn’t want to pry too deeply. But normally when I went in, I was just talking to them, but I don’t know, I felt it was much more deep,” she explained.
The impact of King Charles’ diagnosis has been significant, with a noted 12% increase in male visitors to Maggie’s centres since the news broke. Camilla expressed her desire to see a Maggie’s centre in every major city throughout the UK, underscoring her commitment to cancer support and awareness.
The Queen has made distinct remarks regarding her husband’s health since the announcement. In September 2024, during a visit to the Dyson Cancer Centre at Royal United Hospital in Bath, she shared that Charles was “doing very well.” More recently, in December 2025, it was revealed that his treatment regimen would be reduced in the following year, indicating a positive trend in his recovery.
While avoiding the term “remission,” a representative from Buckingham Palace has confirmed that the King is responding exceptionally well to his treatment. “His Majesty has responded exceptionally well to treatment, and his doctors advise that ongoing measures will now move into a precautionary phase,” the spokesperson stated.
In a rare admission about his own health struggles, King Charles remarked on his treatment while visiting Guy’s Cancer Centre in London in May. He empathised with a patient undergoing chemotherapy, revealing the unpleasant side effects of treatment. “It’s an awful sort of metallic taste. It doesn’t exactly help with eating,” he noted, showcasing his understanding of the challenges faced by those battling cancer.
Queen Camilla’s recent reflections not only shed light on the personal challenges the royal family faces but also highlight the essential work carried out by organisations such as Maggie’s. Her insights underscore her commitment to support those affected by cancer and draw attention to the significance of charitable initiatives in providing crucial care and understanding for families navigating similar journeys.